Sandra Vermeulen

Swedish Medical Center

Papers

2

Total Citations

5

H-Index

2

About

Dr. Sandra Vermeulen is a pioneering radiation oncologist whose work has fundamentally advanced the application of stereotactic body radiation therapy (SBRT) for early-stage breast cancer. Her research focuses on refining non-invasive, high-precision radiation techniques to offer patients a targeted alternative to traditional surgery. Dr. Vermeulen’s major contributions include demonstrating the feasibility and safety of using a robotic linear accelerator to deliver SBRT, establishing a new paradigm for breast cancer treatment that minimizes damage to surrounding healthy tissue. Her landmark 2017 study, cited 3 times, provided the initial clinical evidence for this approach, while her 2020 multi-institutional trial, with 2 citations, confirmed longer-term efficacy and broader applicability. These works have helped pave the way for less invasive, outpatient-based breast cancer care, significantly impacting patient quality of life. Dr. Vermeulen’s dedication to rigorous clinical investigation continues to shape the future of radiation oncology, offering hope for more personalized and effective cancer therapies.

Research Focus

Key Achievements

2
H-Index
2
Papers
5
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Stereotactic Body Radiation Therapy for Early-Stage Breast Cancer Using a Robotic Linear Accelerator
3 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Swedish Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago